HRT Financial’s KALA BIO KALA Stock Holding History

HRT Financial’s Portfolio KALA Stock Details KALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-6	Closed	-$3K	–	2813
2022 Q3	$3K	Sell	6 -10	-63%	-$7.85K	﹤0.01%	2630
2022 Q2	$11K	Buy	+16	New	+$25.1K	﹤0.01%	2668
2022 Q1	–	Sell	-17	Closed	-$52K	–	3472
2021 Q4	$52K	Buy	+17	New	+$78.9K	﹤0.01%	2839
2020 Q4	–	Sell	-21	Closed	-$394K	–	2157
2020 Q3	$394K	Buy	+21	New	+$483K	0.01%	997
2020 Q1	–	Sell	-7	Closed	-$60K	–	1064
2019 Q4	$60K	Buy	+7	New	+$67.6K	﹤0.01%	1063

Other funds holding KALA

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

BOTOTLSJU

Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HRT Financial's KALA Position: Q4 2022 in Review

HRT Financial sold out of KALA BIO (KALA) in Q4 2022, closing a stake of 6 shares — an estimated $3K sold.

HRT Financial first reported a position in KALA in Q4 2019 and held it in 5 quarters. The position peaked at $394K in Q3 2020. 28 funds tracked by Wall St. Rank hold KALA as of Q4 2022.

HRT Financial reported no remaining KALA BIO position as of Q4 2022 after selling out during the quarter.
HRT Financial sold 6 KALA BIO shares in Q4 2022, an estimated $3K.
HRT Financial first reported a position in KALA BIO in Q4 2019 and held it in 5 quarters.
HRT Financial's KALA BIO position peaked at $394K in Q3 2020.
28 funds tracked by Wall St. Rank held KALA BIO as of Q4 2022.

Based on HRT Financial's 13F filing for Q4 2022, filed 10 Feb 2023.